Raise standards for preclinical cancer research
Top Cited Papers
- 28 March 2012
- journal article
- Published by Springer Nature in Nature
- Vol. 483 (7391) , 531-533
- https://doi.org/10.1038/483531a
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Drug development and clinical trials—the path to an approved cancer drugNature Reviews Clinical Oncology, 2012
- Believe it or not: how much can we rely on published data on potential drug targets?Nature Reviews Drug Discovery, 2011
- High drug attrition rates—where are we going wrong?Nature Reviews Clinical Oncology, 2011
- Raising the bar for cancer therapy modelsNature Biotechnology, 2010
- Do Pressures to Publish Increase Scientists' Bias? An Empirical Support from US States DataPLOS ONE, 2010